In the latest from Pharma Live, Adriano Botter, Executive Product Director at 90NORTH, shares his perspective on how natural language processing (NLP), a facet of AI, can impact the pharmaceutical industry.
He explains that NLP “can make sense of the vast amount of unstructured data,” allowing for a detailed understanding of behaviors and preferences that pharmacuetical companies can then use to inform their strategy.
“Through its lens, pharmaceutical companies gain a comprehensive and objective view of factors affecting health outcomes, transcending traditional boundaries,” Adriano said. “This approach incorporates patient decision, engagement, adherence behaviors, and socio-economic factors to improve treatment results.”
